Successful Treatment with CAR- T Cells in a Patient with Immune Thrombocytopenia Associated with Castleman Disease
Journal Title: Diseases & Research - Year 2022, Vol 2, Issue 1
Abstract
Multicentric Castleman disease (MCD), a rare lymphoproliferative disorder of incompletely understood etiology, is manifested as enlarged multiple lymph node and multiple organs involvement. The best therapeutic option for this disease remains unknown. A 21-year-old male patient of MCD with swilling lymph nodes received combination chemotherapy treatment with unsatisfactory efficacy. He developed thrombocytopenia during disease progression and failed steroid treatment. His platelet increased to normal level on day 27 of receiving infusion of humanised anti-CD19 chimeric antigen receptor (CAR) T cells (1 × 106 cells/kg) and murine anti-BCMA CAR T cells (0.6 × 106 cells/kg). He has a stable platelet count and no evidence of progression of lymphadenopathy for 45 months at this writing. This case report reminds clinicians to be aware of the potential clinical value of CAR T cells therapy in MCD.
Authors and Affiliations
Xiaotian Zhang, Hai Cheng
Keywords
Related Articles
- EP ID EP740158
- DOI 10.54457/DR.202201003
- Views 27
- Downloads 0
HBeAg Negativity is Associated with a Higher Risk of Liver-Related Death in Patients with Chronic Hepatitis B Related Liver Cirrhosis
Background and aims Few studies reported the association between the survival of patients with chronic hepatitis B (CHB)-related liver cirrhosis (LC) and hepatitis B e antigen (HBeAg) state. Methods Three hundred and ni...
Update Review of the Relationship Between Gut Microbiota and Neurodegenerative Diseases
Neurodegenerative disease is characterized by progressive deterioration of function or structure of nerve cells in central nervous system, mainly manifested as declined cognitive function and impaired motor behavior. Its...
Recurrent Middle Ear Cancer: Case Report
Background: Middle ear cancer is clinically uncommon, representing approximately 1.5% of ear malignancies and 0.03% to 0.06% of all cancers. Recurrent cases of middle ear cancer are particularly rare. This report discuss...
Is Preoperative Radiotherapy Necessary for Resectable Locally Advanced Squamous Cell Esophageal Carcinoma?
Based on the guidelines for esophageal and esophagogastric junction cancers, the standard of care for resectable locally advanced (cT2, N0 [high-risk lesions: lymphovascular invasion, ≥3 cm, poorly differentiated]; cT1b-...
An Analysis of Gut Bacterial and Fungal Community Interactions in Saxifraga stolonifera Curt.-Treated Mice
Backgrounds Saxifraga stoloniferaCurt. is valued for its great medicinal potentials, especially for anti-inflammatory activity. The gut microbiome is gradually regarded as a pivotal part that contributes to the therapeut...